Cellular factors required for Lassa virus budding.

PubWeight™: 2.02‹?› | Rank: Top 2%

🔗 View Article (PMC 1440458)

Published in J Virol on April 01, 2006

Authors

Shuzo Urata1, Takeshi Noda, Yoshihiro Kawaoka, Hideyoshi Yokosawa, Jiro Yasuda

Author Affiliations

1: First Department of Forensic Science, National Research Institute of Police Science, Kashiwa 277-0882, Japan.

Articles citing this

Inhibition of Lassa and Marburg virus production by tetherin. J Virol (2008) 3.98

Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology (2007) 2.68

Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. J Virol (2007) 1.81

Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J Virol (2010) 1.48

Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol (2010) 1.44

Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies. J Virol (2007) 1.33

Arenavirus Z-glycoprotein association requires Z myristoylation but not functional RING or late domains. J Virol (2007) 1.27

Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog (2011) 1.25

Antiviral activity of innate immune protein ISG15. J Innate Immun (2009) 1.25

Dimerization of tetherin is not essential for its antiviral activity against Lassa and Marburg viruses. PLoS One (2009) 1.22

Efficient budding of the tacaribe virus matrix protein z requires the nucleoprotein. J Virol (2010) 1.20

No exit: targeting the budding process to inhibit filovirus replication. Antiviral Res (2008) 1.18

Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease. J Virol (2010) 1.17

Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol (2009) 1.17

The RING domain and the L79 residue of Z protein are involved in both the rescue of nucleocapsids and the incorporation of glycoproteins into infectious chimeric arenavirus-like particles. J Virol (2009) 1.13

Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses (2010) 1.11

The z protein of the new world arenavirus tacaribe virus has bona fide budding activity that does not depend on known late domain motifs. J Virol (2009) 1.10

A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J Virol (2010) 1.10

Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology (2011) 1.10

CHMP7, a novel ESCRT-III-related protein, associates with CHMP4b and functions in the endosomal sorting pathway. Biochem J (2006) 1.09

Junín virus pathogenesis and virus replication. Viruses (2012) 1.07

Envelope glycoprotein of arenaviruses. Viruses (2012) 1.06

Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease. J Virol (2010) 1.06

Junín virus infection activates the type I interferon pathway in a RIG-I-dependent manner. PLoS Negl Trop Dis (2012) 1.05

ALIX/AIP1 is required for NP incorporation into Mopeia virus Z-induced virus-like particles. J Virol (2011) 1.04

Vacuolar protein sorting pathway contributes to the release of Marburg virus. J Virol (2008) 0.99

Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses. J Virol (2014) 0.99

A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding. Virology (2008) 0.97

A virus-like particle-based Epstein-Barr virus vaccine. J Virol (2011) 0.92

Cloning and characterization of the antiviral activity of feline Tetherin/BST-2. PLoS One (2011) 0.92

Multifunctional nature of the arenavirus RING finger protein Z. Viruses (2012) 0.92

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Virol J (2010) 0.92

Viral takeover of the host ubiquitin system. Front Microbiol (2011) 0.90

Conserved residues in Lassa fever virus Z protein modulate viral infectivity at the level of the ribonucleoprotein. J Virol (2011) 0.88

The PI3K/Akt pathway contributes to arenavirus budding. J Virol (2012) 0.87

Arenavirus budding. Adv Virol (2011) 0.87

Reverse genetics approaches to combat pathogenic arenaviruses. Antiviral Res (2008) 0.85

Biological roles and functional mechanisms of arenavirus Z protein in viral replication. J Virol (2012) 0.85

Cellular VPS4 is required for efficient entry and egress of budded virions of Autographa californica multiple nucleopolyhedrovirus. J Virol (2011) 0.83

Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects. Virol J (2010) 0.83

Molecular mechanism of arenavirus assembly and budding. Viruses (2012) 0.83

Arenavirus budding: a common pathway with mechanistic differences. Viruses (2013) 0.83

Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses. Expert Opin Drug Discov (2012) 0.82

Viral and cellular requirements for the budding of feline endogenous retrovirus RD-114. Virol J (2011) 0.82

Molecular determinants of arenavirus Z protein homo-oligomerization and L polymerase binding. J Virol (2011) 0.81

Identification and functional analysis of three isoforms of bovine BST-2. PLoS One (2012) 0.80

Regulation of HTLV-1 Gag budding by Vps4A, Vps4B, and AIP1/Alix. Virol J (2007) 0.80

Budding of Enveloped Viruses: Interferon-Induced ISG15-Antivirus Mechanisms Targeting the Release Process. Adv Virol (2012) 0.79

Arenavirus stable signal peptide is the keystone subunit for glycoprotein complex organization. MBio (2014) 0.79

Antigenic properties of N protein of hantavirus. Viruses (2014) 0.79

ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding. J Virol (2016) 0.78

Permeability changes of integrin-containing multivesicular structures triggered by picornavirus entry. PLoS One (2014) 0.78

Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid. Antiviral Res (2013) 0.77

Uncovering viral protein-protein interactions and their role in arenavirus life cycle. Viruses (2012) 0.77

Antigen vehiculization particles based on the Z protein of Junin virus. BMC Biotechnol (2012) 0.77

Quinoxaline-based inhibitors of Ebola and Marburg VP40 egress. Bioorg Med Chem Lett (2016) 0.76

Identification of conserved motifs in the West Nile virus envelope essential for particle secretion. BMC Microbiol (2013) 0.76

Expression and purification of Z protein from Junín virus. J Biomed Biotechnol (2010) 0.76

The Lymphocytic Choriomeningitis Virus Matrix Protein PPXY Late Domain Drives the Production of Defective Interfering Particles. PLoS Pathog (2016) 0.76

Arenavirus budding resulting from viral-protein-associated cell membrane curvature. J R Soc Interface (2013) 0.76

Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses. Viruses (2016) 0.75

Budding of Tiger Frog Virus (an Iridovirus) from HepG2 Cells via Three Ways Recruits the ESCRT Pathway. Sci Rep (2016) 0.75

A systems biology starter kit for arenaviruses. Viruses (2012) 0.75

Analysis of Assembly and Budding of Lujo Virus. J Virol (2015) 0.75

Reverse Genetics Approaches to Control Arenavirus. Methods Mol Biol (2016) 0.75

Ubiquitin Ligase WWP1 Interacts with Ebola Virus VP40 to Regulate Egress. J Virol (2017) 0.75

Articles cited by this

Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell (2001) 12.00

Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A (1991) 10.05

p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol (1995) 6.87

An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol (1994) 5.87

Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (1998) 5.83

A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci U S A (2000) 5.30

Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J Virol (1995) 4.92

Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci U S A (2003) 4.21

Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol (1997) 4.08

Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J Virol (1996) 3.97

A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol (1999) 3.92

A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release. J Virol (1998) 3.69

Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J (1999) 3.67

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62

The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A (2003) 3.34

Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J Virol (2003) 3.05

Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci U S A (2001) 3.04

Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol (2000) 2.97

Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol (2003) 2.87

AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell (2005) 2.68

Functional involvement of a novel Nedd4-like ubiquitin ligase on retrovirus budding. EMBO Rep (2002) 2.22

Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol (2003) 2.19

The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. J Virol (2003) 2.19

Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol (2005) 1.88

PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected]. J Virol (2003) 1.80

Budding of PPxY-containing rhabdoviruses is not dependent on host proteins TGS101 and VPS4A. J Virol (2004) 1.64

Late domain-dependent inhibition of equine infectious anemia virus budding. J Virol (2004) 1.57

Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res (2004) 1.54

AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding. J Virol (2005) 1.44

Role of Nedd4 and ubiquitination of Rous sarcoma virus Gag in budding of virus-like particles from cells. J Virol (2004) 1.27

Regulation of human T-cell leukemia virus type 1 (HTLV-1) budding by ubiquitin ligase Nedd4. Microbes Infect (2004) 1.07

Articles by these authors

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59

Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature (2012) 14.17

Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy (2007) 11.74

Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature (2008) 11.39

Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34

Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40

Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62

A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat Cell Biol (2009) 7.84

Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56

Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol (2009) 7.35

The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell (2008) 6.66

Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature (2004) 6.11

PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology (2004) 5.96

Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28

Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J Virol (2006) 5.26

Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52

Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 4.49

Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci U S A (2009) 4.48

Autophagosomes form at ER-mitochondria contact sites. Nature (2013) 4.32

Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol (2009) 4.20

Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature (2008) 4.18

An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure. Mol Biol Cell (2008) 4.00

Inhibition of Lassa and Marburg virus production by tetherin. J Virol (2008) 3.98

Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77

Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71

Gain-of-function experiments on H7N9. Science (2013) 3.67

Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog (2010) 3.65

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62

The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science (2012) 3.50

Leaf senescence and starvation-induced chlorosis are accelerated by the disruption of an Arabidopsis autophagy gene. Plant Physiol (2002) 3.47

Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45

Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27

The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19

Processing of ATG8s, ubiquitin-like proteins, and their deconjugation by ATG4s are essential for plant autophagy. Plant Cell (2004) 3.17

Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA (2007) 3.00

Autophagy requires endoplasmic reticulum targeting of the PI3-kinase complex via Atg14L. J Cell Biol (2010) 2.98

The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol (2005) 2.89

A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol (2007) 2.80

Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. Virology (2005) 2.77

Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis (2006) 2.72

Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol (2006) 2.70

Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol (2003) 2.67

Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog (2009) 2.62

Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol (2006) 2.60

Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog (2010) 2.60

Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol (2002) 2.58

Human infection with highly pathogenic H5N1 influenza virus. Lancet (2008) 2.57

Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol (2005) 2.55

Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. Cell Struct Funct (2008) 2.47

Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol (2005) 2.45

Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog (2009) 2.44

Molecular determinants of Ebola virus virulence in mice. PLoS Pathog (2006) 2.44

Selection of H5N1 influenza virus PB2 during replication in humans. J Virol (2009) 2.42

Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol (2004) 2.34

An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A (2005) 2.33

Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32

High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol (2010) 2.29

Self-assembly of concentric quantum double rings. Nano Lett (2005) 2.27

Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol (2006) 2.24

Pause on avian flu transmission research. Science (2012) 2.24

Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1. J Infect Dis (2012) 2.24

Cellular networks involved in the influenza virus life cycle. Cell Host Microbe (2010) 2.23

In vivo and in vitro reconstitution of Atg8 conjugation essential for autophagy. J Biol Chem (2004) 2.21

Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol (2003) 2.19

Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol (2005) 2.09

Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol (2004) 2.09

The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol (2006) 2.07

An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China. Virology (2011) 2.05

A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc Natl Acad Sci U S A (2009) 2.04

Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep (2003) 2.01

Monitoring autophagy in mammalian cultured cells through the dynamics of LC3. Methods Enzymol (2009) 1.99

Chemical modulators of autophagy as biological probes and potential therapeutics. Nat Chem Biol (2011) 1.97

Ebola virus VP40 late domains are not essential for viral replication in cell culture. J Virol (2005) 1.97

The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol (2011) 1.95

Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome. EMBO J (2009) 1.93

High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J Infect Dis (2003) 1.89

Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol (2003) 1.88

The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol (2012) 1.84

A shared structural solution for neutralizing ebolaviruses. Nat Struct Mol Biol (2011) 1.84

The early secretory pathway contributes to autophagy in yeast. Cell Struct Funct (2003) 1.83

Toward unraveling membrane biogenesis in mammalian autophagy. Curr Opin Cell Biol (2008) 1.83

Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. J Virol (2007) 1.81